Reglagene is the product of research from the labs of Professor Laurence Hurley at the University of Arizona. Professor Hurley discovered that DNA quadruplexes in gene promoter regions serve as master control elements for gene expression.
Pioneering the field
Professor Hurley pioneered Quadruplex Master Switch Technology (QMST) to discover small molecule medicines that fight disease through the control of gene expression.
The pharmaceutical R&D landscape continues to evolve. The rapid advancement of biomedical technology and the cost of maintaining ever-ready R&D capacity have conspired to create a shift in the pharmaceutical business model. Once the exclusive domain of major companies, pharmaceutical discovery is increasingly distributed among innovative startup companies.